Marcel van den Brink

At-a-Glance

President, City of Hope Los Angeles and National Medical Center, and Deana and Steve Campbell Chief Physician Executive Distinguished Chair.
Known for research in hematopoietic stem cell transplantation, intestinal microbiome, CAR therapy, and thymic regeneration.
Discovered that antibiotic treatment slows immune cell regrowth, lactose feeds dangerous gut bacteria, and Blautia producta can prevent infections and GVHD in bone marrow transplant patients.
Elected Foreign Member of Medical, Biomedical and Health Sciences to the Royal Netherlands Academy of Arts and Sciences (KNAW).
Vice Chairman of DKMS Stiftung Leben Spenden Foundation Board and Chairman of the DKMS Medical Council.
Obtained M.D. and Ph.D. from the University of Leiden.

Biography

Marcel R.M. van den Brink, MD, PhD, is a Dutch oncologist and physician-scientist. He currently serves as President of City of Hope Los Angeles and National Medical Center, holding the Deana and Steve Campbell Chief Physician Executive Distinguished Chair. His clinical work focuses on patients undergoing bone marrow transplants for blood cancers like leukemia, while his laboratory research explores questions related to this treatment and general cancer immunotherapy.

Dr.